What patients and payers pay for 340B drugs: 6 study notes
An October report from Berkeley Research Group estimates how much patients and payers spend on 340B drugs, beyond what covered entities pay to acquire them. Becker's Hospital Review
An October report from Berkeley Research Group estimates how much patients and payers spend on 340B drugs, beyond what covered entities pay to acquire them. Becker's Hospital Review